title: The Tri-State Experience. Outcome Analysis of Patients with Triple Negative Breast Cancer Treated at Marshall University.
abstract: Breast cancer is the most frequently diagnosed malignancy in women in the United States. It is the second most common malignancy to cause death, with approximately 39,000 women dying of breast cancer in the United States in 2013. Triple negative breast cancer is defined as the absence of estrogen, progesterone and human epidermal growth factor receptor 2 receptors. It has been associated with a higher incidence in African American women, a younger age and a more advanced stage at diagnosis, and an inferior overall survival. To recognize the differences of our West Virginia community population when compared to the national average, we conducted a retrospective review of all patients diagnosed with breast cancer from 2000-2012.
authors.forename: Laurie
authors.initials: L
authors.lastname: Matt
authors.forename: Mohammad
authors.initials: M
authors.lastname: Mozayen
authors.forename: Todd
authors.initials: T
authors.lastname: Gress
authors.forename: Maria Tria
authors.initials: MT
authors.lastname: Tirona
mesh_terms: D001741:Black or African American; D005260:Female; D006785:Hospitals, University; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D017063:Outcome Assessment, Health Care; D012189:Retrospective Studies; D015996:Survival Rate; D064726:Triple Negative Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy; D014903:West Virginia; D044465:White People